Search Results - "Spasov, B."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    UBVRI observations of the flickering of RS Ophiuchi at quiescence by Zamanov, R. K., Boeva, S., Bachev, R., Bode, M. F., Dimitrov, D., Stoyanov, K. A., Gomboc, A., Tsvetkova, S. V., Slavcheva-Mihova, L., Spasov, B., Koleva, K., Mihov, B.

    “…We report observations of the flickering variability of the recurrent nova RS Oph at quiescence on the basis of simultaneous observations in five bands…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    1073PPrognostic factors influencing outcome after therapy with brentuximab vedotin in patients with relapsed or refractory Hodgkin’s lymphoma by Goranova-Marinova, V S, Ignatova, K, Ganeva, P, Spasov, E, Arnaudov, G, Micheva, I, Gercheva, L, Radinov, A, Petrova, R, Tzvetkova, G, Hadzhiev, E, Bogdanov, L, Tzvetkov, N, Spasov, B, Grudeva-Popova, Z, Tumbeva, D

    Published in Annals of oncology (01-10-2019)
    “…Abstract Background Brentuximab Vedotin (BV) treatment has improved the prognosis and survival of patients with Hodgkin’s lymphoma, relapsed after stem cell…”
    Get full text
    Journal Article
  6. 6

    PB1756 EFFICACY OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA SINGLE CENTER EXPERIENCE by Simeonova, K., Nikolova, V., Naseva, E., Stoychov, M., Yankova, T., Donchev, M., Arnaudov, G., Balazenkou, G., Guenova, M., Spasov, B.

    Published in HemaSphere (01-06-2019)
    “…Background: Although understanding in the pathology of AML has developed and a variety of new therapies to AML have been found recently, no response to…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11